This month’s podcast I explore some of the February 2014 Nature Careers and Naturejobs articles with Monya Baker, and I speak to three people about three projects that are looking to increase support available for early career researchers and their career transitions. Read more
In May this year, Vitae and Naturejobs co-launched a survey: What do research staff do next? The goal of this survey, according to Dr Janet Metcalfe, Chair and Head of Vitae, is to “create a range of career stories of former research staff that reveals their career journeys and explores what were the tipping points in their careers.” … Read more
On this Naturejobs blog we’ve looked at quite a few things on moving from academia to industry: we spoke to Nessa Carey from Pfizer on her transition from academia to industry, we’ve written about transferable skills that are needed, we’ve been through our archives to find you some great reads on our Windback Wednesday round-up: From academia to industry. We’ve even looked at how to find your path when leaving the academic track. Read more
Researchers rely heavily on networking at conferences and seminars and make little use of personal introductions, online social networking or proactive self-promotion, according to a report published by UK researcher development organisation Vitae. Read more
Posted on behalf of Hywel Curtis What would it take for your research to go global? At Vitae’s international researcher development conference, held in Manchester in the United Kingdom last week, several speakers offered advice on how to boost your international profile. It’s an expanding area of interest: Emma Gillaspy, Vitae’s north-west hub manager, explains that institutions throughout academia are looking at how they can support the development of truly global researchers, and half of respondents to a recent Naturejobs poll said it was ‘very important’ for young researchers to work abroad early in their careers. Furthermore, an increasing focus … Read more
The impending hike in university tuition fees in the UK is prompting companies to offer to shoulder the financial burden in order to attract top graduate talent. Pharma giant GlaxoSmithKline (GSK) followed the lead of accounting firm KPMG on Wednesday by announcing that it will reimburse tuition fees to all its UK recruits from September 2012. It’s an enticing deal – worth up to £27,000 for those taking a three-year degree – but what are the wider implications? Read more